Centric Health Corp. (TSE:CRX – Free Report) – Stock analysts at Leede Financial reduced their FY2025 EPS estimates for Centric Health in a research note issued on Monday, November 11th. Leede Financial analyst D. Loe now anticipates that the company will post earnings per share of ($0.01) for the year, down from their previous forecast of $0.01. Leede Financial also issued estimates for Centric Health’s FY2026 earnings at $0.01 EPS.
Several other brokerages have also recently issued reports on CRX. Ventum Cap Mkts upgraded shares of Centric Health to a “strong-buy” rating in a research report on Thursday, August 8th. Stifel Canada downgraded Centric Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 12th.
Centric Health Price Performance
Featured Articles
- Five stocks we like better than Centric Health
- What Are Growth Stocks and Investing in Them
- Top 3 R&D-Driven Stocks Showing Strong Profit and Momentum
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Shopify Stock Rally Continues: Why the Growth Story Isn’t Over
- How to invest in marijuana stocks in 7 steps
- Tariff Troubles: 3 Stocks Planning Higher Prices
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
